{"id":8098,"date":"2025-07-24T14:19:19","date_gmt":"2025-07-24T11:19:19","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=8098"},"modified":"2025-07-24T14:20:56","modified_gmt":"2025-07-24T11:20:56","slug":"early-and-intensive-lipid-lowering-to-prevent-acs","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/early-and-intensive-lipid-lowering-to-prevent-acs\/","title":{"rendered":"Early and Intensive Lipid-Lowering to Prevent ACS"},"content":{"rendered":"<div>Early and Intensive Lipid-Lowering to Prevent ACS<\/div>\n<div><\/div>\n<div>ESC Congress 2025 \u2013 IFEMA Madrid<\/div>\n<div>August 30, 2025 | 10:00\u201310:45 CEST<\/div>\n<div>Getting-Ahead-of-the-Curve-Lipid-Lowering-ACS<\/div>\n<div><\/div>\n<div>Scientific Summary \u2013 Key Points:<\/div>\n<div><span> 1. ASCVD is often diagnosed too late, after irreversible arterial damage has occurred.<\/span><\/div>\n<div><span> 2. Early identification of high-risk patients is critical to prevent acute coronary syndrome (ACS).<\/span><\/div>\n<div><span> 3. Aggressive LDL-C lowering stabilizes coronary plaques and reduces the risk of major cardiac events.<\/span><\/div>\n<div><span> 4. Recommended therapies include:<\/span><\/div>\n<div><span> \u2022 High-intensity statins<\/span><\/div>\n<div><span> \u2022 Ezetimibe<\/span><\/div>\n<div><span> \u2022 PCSK9 inhibitors<\/span><\/div>\n<div><span> 5. Clinical case discussions guided participants in applying evidence-based lipid-lowering strategies to prevent ACS.<\/span><\/div>\n<div><\/div>\n<div><a href=\"http:\/\/www.escardio.org\/Congresses-&amp;-Events\/ESC-Congress\/\">http:\/\/www.escardio.org\/Congresses-&amp;-Events\/ESC-Congress\/<\/a><\/div>\n<div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Early and Intensive Lipid-Lowering to Prevent ACS ESC Congress 2025 \u2013 IFEMA Madrid August 30, 2025 | 10:00\u201310:45 CEST Getting-Ahead-of-the-Curve-Lipid-Lowering-ACS Scientific Summary \u2013 Key Points: 1. ASCVD is often diagnosed too late, after irreversible arterial damage has occurred. 2. Early identification of high-risk patients is critical to prevent acute coronary syndrome (ACS). 3. Aggressive LDL-C [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8098","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8098","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=8098"}],"version-history":[{"count":2,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8098\/revisions"}],"predecessor-version":[{"id":8103,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/8098\/revisions\/8103"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=8098"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=8098"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=8098"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}